Publicaciones en colaboración con investigadores/as de University Health Network (18)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Guiding the global evolution of cytogenetic testing for hematologic malignancies

    Blood, Vol. 139, Núm. 15, pp. 2273-2284

2021

  1. Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

    New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802

2019

  1. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

    The Lancet Neurology, Vol. 18, Núm. 1, pp. 46-55

2018

  1. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 18, Núm. 10, pp. e401-e419

2014

  1. Immune response to influenza A(H1N1)v in HIV-infected patients

    Journal of Infection in Developing Countries, Vol. 8, Núm. 1, pp. 101-109

2011

  1. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

    BMC Infectious Diseases, Vol. 11

  2. Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza

    Critical Care

  3. Inflammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity

    PLoS Neglected Tropical Diseases, Vol. 5, Núm. 8

2010

  1. Host adaptive immunity deficiency in severe pandemic influenza

    Critical Care, Vol. 14, Núm. 5

2009

  1. Considerations for the control of background fluorescence in clinical flow cytometry

    Cytometry Part B - Clinical Cytometry, Vol. 76, Núm. 6, pp. 355-364

  2. Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains

    Journal of Infection in Developing Countries, Vol. 3, Núm. 3, pp. 159-161

  3. Nasopharyngeal aspirate cytokine levels 1 yr after severe respiratory syncytial virus infection

    Pediatric Allergy and Immunology, Vol. 20, Núm. 8, pp. 791-795

  4. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza

    Critical Care, Vol. 13, Núm. 6

2008

  1. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets

    Journal of Virology, Vol. 82, Núm. 22, pp. 11308-11317

  2. Human immunopathogenesis of severe acute respiratory syndrome (SARS)

    Virus Research, Vol. 133, Núm. 1, pp. 13-19

2007

  1. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

    Journal of Virology, Vol. 81, Núm. 16, pp. 8692-8706

  2. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children

    Journal of Allergy and Clinical Immunology